The Latest Breaking News from Vaccine

Pfizer Inc. and BioNTech SE said their COVID-19 vaccine was highly effective and prompted a strong immune response in children under age 5, based on early results from a trial that is likely to pave the way for infants and toddlers to finally get immunized.

The FDA has lifted the clinical hold on Ocugen Inc's (NASDAQ:OCGN) Phase 2/3 trial, OCU-002, for Covaxin (BBV152), a whole virus inactivated COVID-19 vaccine candidate.  In April, the agency paused the trials of the shot, Covaxin, after an inspection of a Bharat Biotech facility by the World Health Organization (WHO) revealed deficiencies…

Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.

THE first case of monkeypox has been confirmed in Scotland, as the total grows across the UK.

Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week

Pfizer reported three doses of its vaccine in kids under five produced a strong immune response and was safe.

As many of us flock abroad to enjoy a long-awaited holiday, here are all the rules you need to know for some of the most popular destinations we'll no doubt be flying to

The UK Health Security Agency (UKHSA) guidance now recommends that people in close contact should isolate for three weeks.

The First Minister urged people to get all their doses of the vaccine, adding that she feels ‘extremely grateful’ to have been vaccinated.